The National Cancer Institute (NCI) employs a variety of technologies and methodologies to enhance cancer research and improve patient care. One significant focus is on clinical trials, which are essential for evaluating new treatments and understanding their effectiveness across diverse populations. NCI emphasizes the importance of increasing participation from underrepresented groups, particularly Black patients, who historically have been hesitant to enroll in clinical research due to mistrust and spiritual beliefs. To address these issues, NCI is actively working on strategies to engage these communities, including conducting surveys to better understand their perspectives and concerns regarding clinical trials.

Additionally, NCI supports researchers through various resources, including funding opportunities and training programs, to foster a robust cancer research workforce. The organization is committed to optimizing the workforce to reflect the diversity of the populations affected by cancer, ensuring that research outcomes are applicable and beneficial to all demographic groups. By focusing on these initiatives, NCI aims to advance cancer treatment and prevention while addressing disparities in clinical trial participation and outcomes.

United States

The National Cancer Institute (NCI) is the federal government's principal agency for cancer research and training.

National Cancer Institute

Company Details